The good news at the end of the year was that the FDA approved a pill form of the company's GLP-1 weight loss medication. The ...

"Neumora’s Alzheimer’s disease agitation drug shows early success in Phase Ib trial" was originally created and published by ...

Collaboration to Improve Access to Study for Alzheimer’s DiseaseLAS VEGAS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Today, Global ...

The study also leveraged advanced diagnostic tools to identify early biomarkers of cognitive decline in individuals with a ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...

Tv Therapeutics (VTVT) is a $156 million biopharma focused on small molecule drugs for Alzheimer’s, diabetes, and ...

Neumora Therapeutics (NMRA) stock jumps as the company posts early-stage trial data for its experimental drug for Alzheimer’s ...

By Dennis Thompson HealthDay ReporterTUESDAY, Jan. 6, 2026 (HealthDay News) — A mail-in blood test accurately detects markers ...

A new international study has demonstrated that Alzheimer's disease biomarkers can be accurately detected using simple finger ...

Researchers discovered that clogged brain “drains” show up early in people at risk of Alzheimer’s disease. These blockages, ...

Adherence to a structured lifestyle intervention was nonsuperior to a self-guided intervention regarding impact on ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as ...